CoLucid Pharmaceuticals, Inc. 4
4 · CoLucid Pharmaceuticals, Inc. · Filed May 7, 2015
Insider Transaction Report
Form 4
Dallas Matthew D
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2015-05-05+180,254→ 180,254 totalExercise: $10.00Exp: 2025-05-05→ Common Stock (180,254 underlying)
Footnotes (1)
- [F1]Options vest as follows: 25% of the shares vest on May 5, 2016; and the remaining shares vest in a series of 36 successive equal monthly installments upon completion of each additional month of service.